Some interesting but not yet published results/methods
1) Parametric equation to assess the probability a treatment is cost-effective.
2) An ex-post adjustment method to account for uncertainty in the joint empirical distribution of incremental cost and effectiveness.
Link to Google Scholar page
Link to National Library of Medicine bibliography.
Download Poster from SMDM 2022 — “Not another correlation coefficient: A method to adjust cost-effectiveness acceptability curves in economic evaluations.”
Select, first-authored publications
Jalali A. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies. Expert Review of Pharmacoeconomics & Outcomes Research. 2024. (in press) https://doi.org/10.1080/14737167.2024.2350561
Jalali A, McPherson SM, Tamimi R, Murphy SM. Econometric Issues in prospective ecoonomic evaluations alongside clinical trials: Combining the nonparametric bootstrap with methods that address missing data. Epidemiological Reviews. 2022. 4(1): 67-77. https://doi.org/10.1093/epirev/mxac006
Jalali A, Jeng PJ, Polsky D, Pool S, Ku YC, Woody GE, Murphy SM. Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid used disorder before release from prison verses after release. Journal of Substance Abuse Treatment. 2022 Oct; 114: 1008825. https://doi.org/10.1016/j.jsat.2022.108835
Jalali A, Ryan DA, Jeng PJ, McCollister KE, Leff JA, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR, Murphy SM. Health-related quality of life and Opioid Use Disorder pharmacotherapy: A secondary analysis of a clinical trial. Drug and Alcohol Dependence. 2020 Oct; 218: 108221. https://doi.org/10.1016/j.drugalcdep.2020.108221
Jalali A, Rothwell E, Botkin JR, Anderson RA, Butterfield RJ, Nelson RE. Cost-Effectiveness of nusinersen and universal newborn screening for Spinal Muscular Atrophy. Journal of Pediatrics. 2020 Jul; 227: Pages 274-280.e2. https://doi.org/10.1016/j.jpeds.2020.07.033
Jalali A, Ryan DA, McCollister KE, Marsch LA, Schackman BR, Murphy SM. Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future. Journal of Substance Abuse Treatment. 2020 Mar; 112S: 18-27. https://doi.org/10.1016/j.jsat.2020.02.002
Jalali A, Martin C, Nelson RE, Vanneman ME, Martin BI, Cooney KA, Waitzman NJ, O'Neil B. Provider practice competition and adoption of Medicare's Oncology Care Model. Medical Care. 2020 Feb; 58(2): 154-160. https://doi.org/10.1097/mlr.0000000000001243